Growth Metrics

LifeMD (LFMD) Return on Equity (2016 - 2025)

LifeMD (LFMD) has disclosed Return on Equity for 13 consecutive years, with 1.09% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 461.0% year-over-year to 1.09%, compared with a TTM value of 1.09% through Dec 2025, down 461.0%, and an annual FY2025 reading of 3.15%, up 453.0% over the prior year.
  • Return on Equity was 1.09% for Q4 2025 at LifeMD, up from 6.53% in the prior quarter.
  • Across five years, Return on Equity topped out at 26.22% in Q1 2021 and bottomed at 97.76% in Q3 2022.
  • Average Return on Equity over 5 years is 8.58%, with a median of 1.79% recorded in 2023.
  • The sharpest move saw Return on Equity crashed -10352bps in 2022, then surged 9951bps in 2023.
  • Year by year, Return on Equity stood at 40.21% in 2021, then surged by 117bps to 6.79% in 2022, then decreased by -27bps to 4.96% in 2023, then dropped by -29bps to 3.52% in 2024, then plummeted by -131bps to 1.09% in 2025.
  • Business Quant data shows Return on Equity for LFMD at 1.09% in Q4 2025, 6.53% in Q3 2025, and 6.53% in Q2 2025.